Search PubMed⌕ Search

PubMed · 8471305

General practitioner referral patterns.

Abstract

A survey of general practitioners (GPs) in the Western Health and Social Services Board was carried out in November 1990. The main objectives were to determine the factors which influence GPs' decisions to refer to particular hospitals and to ascertain current out-patient referral patterns. A self-administered questionnaire was sent to 157 GPs. The response rate was 94 per cent. It was found that waiting lists and personal knowledge of consultants' expertise were considered to be of particular importance in making referral decisions for elective/non-urgent procedures. Referrals were usually made to the nearest hospital with a relevant out-patient clinic. The majority (96 per cent) of respondents indicated that they would be willing to change their referral patterns for elective/non-urgent procedures in response to shorter waiting times. It is concluded that GPs may be more willing to change their referral patterns than might have been expected.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

F Kennedy, B McConnell. 1993. General practitioner referral patterns.. https://doi.org/10.1093/oxfordjournals.pubmed.a042824

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Clinically relevant differences between the statins: implications for therapeutic selection.

Although the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, or statins, share a common lipid-lowering effect, there are differences within this class of drugs. The low-density lipoprotein (LDL) cholesterol-lowering efficacy, pharmacokinetic properties, drug-food interactions, and cost can vary widely, thus influencing the selection of a particular statin as a treatment option. The statins that produce the greatest percentage change in LDL cholesterol levels are atorvastatin and simvastatin. Atorvastatin and fluvastatin are least affected by alterations in renal function. Fewer pharmacokinetic drug interactions are likely to occur with pravastatin and fluvastatin, because they are not metabolized through the cytochrome P450 (3A4) system. The most cost-effective statins, based on cost per percentage change in LDL cholesterol levels, are fluvastatin, cerivastatin, and atorvastatin. Awareness of these differences may assist in the selection or substitution of an appropriate statin for a particular patient.

Decision Making↗